In-silico screening of cancer associated mutation on PLK1 protein and its structural consequences

被引:0
|
作者
Balu Kamaraj
Vidya Rajendran
Rao Sethumadhavan
Rituraj Purohit
机构
[1] Vellore Institute of Technology University,School of Bio Sciences and Technology (SBST), Bioinformatics Division
[2] Human Genetics Foundation,undefined
[3] Torino,undefined
来源
Journal of Molecular Modeling | 2013年 / 19卷
关键词
Flexibility; Molecular dynamics simulations; PLK-1 protein;
D O I
暂无
中图分类号
学科分类号
摘要
The Polo-like kinases (Plks) are a conserved subfamily of serine-threonine protein kinases that have significant roles in cell proliferation. The serine/threonine protein kinases or polo-like kinase 1 (PLK1) exist in centrosome during interphase and is an important regulatory enzyme in cell cycle progression during M phase. Mutations in mammalian PLK1 were found to be over expressed in various human cancers and it is disrupting the binding ability of polo box domain with target peptide. In this analysis we implemented a computational approach to filter the most deleterious and cancer associated mutation on PLK1 protein. We found W414F as the most deleterious and cancer associated by Polyphen 2.0, SIFT, I-mutant 3.0, PANTHER, PhD-SNP, SNP&GO, Mutpred and Dr Cancer tools. Molecular docking and molecular dynamics simulation (MDS) approach was used to investigate the structural and functional behavior of PLK1 protein upon mutation. MDS and docking results showed stability loss in mutant PLK1 protein. Due to mutation, PLK1 protein became more flexible and alters the dynamic property of protein which might affect the interaction with target peptide and leads to cell proliferation. Our study provided a well designed computational methodology to examine the cancer associated nsSNPs and their molecular mechanism. It further helps scientists to develop a drug therapy against PLK1 cancer-associated diseases.
引用
收藏
页码:5587 / 5599
页数:12
相关论文
共 50 条
  • [31] In-silico characterization of cadmium stress response-associated Abc1-like protein and its homologues in maize (Zea mays)
    Singh, Alla
    Karjagi, Chikkappa
    Kumar, Ramesh
    Chaudhary, D. P.
    Rakshit, Sujay
    INDIAN JOURNAL OF AGRICULTURAL SCIENCES, 2020, 90 (09): : 1685 - 1689
  • [32] In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches
    Sahayarayan, Jesudass Joseph
    Rajan, Kulanthaivel Soundar
    Vidhyavathi, Ramasamy
    Nachiappan, Mutharasappan
    Prabhu, Dhamodharan
    Alfarraj, Saleh
    Arokiyaraj, Selvaraj
    Daniel, Amalorpavanaden Nicholas
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (01) : 400 - 407
  • [33] The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients
    Kahl, Iris
    Mense, Julian
    Finke, Christopher
    Boller, Anna-Lena
    Lorber, Clara
    Gyorffy, Balazs
    Greve, Burkhard
    Goette, Martin
    Espinoza-Sanchez, Nancy A.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (03) : 581 - 600
  • [34] Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein (vol 7, 46017, 2017)
    Mukhopadhyay, Nishit K.
    Chand, Vaibhav
    Pandey, Akshay
    Kopanja, Dragana
    Carr, Janai R.
    Chen, Yi-Ju
    Liao, Xiubei
    Raychaudhuri, Pradip
    SCIENTIFIC REPORTS, 2018, 8
  • [35] Isolation, Characterization and In-Silico Study of Conotoxin Protein from Conus loroisii and Its Anti-cancer Activity
    Anjali Kumari
    Shijin Ameri
    Najat Marraiki
    Abdallah M. Elgorban
    Vincent Aroulmoji
    Kumar Ponnuchamy
    Muthusamy Govarthanan
    Thangaswamy Selvankumar
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 385 - 395
  • [36] In-silico Evaluation of Novel Honokiol Derivatives against Breast Cancer Target Protein LKB1
    Shahid, Izzah
    Shoaib, Muhammad
    Raza, Rabail Zehra
    Jahangir, Muhammad
    Abbasi, Sumra Wajid
    Riasat, Areej
    Akbar, Ansa
    Mehnaz, Samina
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (12) : 1388 - 1396
  • [37] In Silico Discovery of 5′-Modified 7-Deoxy-7-ethynyl-4′-thioadenosine as a HASPIN Inhibitor and Its Synergistic Anticancer Effect with the PLK1 Inhibitor
    Kwon, Eun-Ji
    Mashelkar, Karishma K.
    Seo, Juhee
    Shin, Yoon-Ze
    Sung, Kisu
    Jang, Sung Chul
    Cheon, Sang Won
    Lee, Haeseung
    Lee, Hyuk Woo
    Kim, Gyudong
    Han, Byung Woo
    Lee, Sang Kook
    Jeong, Lak Shin
    Cha, Hyuk-Jin
    ACS CENTRAL SCIENCE, 2023, 9 (06) : 1140 - 1149
  • [38] In-silico investigation of RPS6KB1 associated cancer inhibitor: a drug repurposing study
    Rajendrasozhan, Saravanan
    Ahmad, Irfan
    Rab, Safia Obaidur
    Alshahrani, Mohammad Y.
    Almuqri, Eman Abdullah
    Siddiqui, Jamshaid Ahmad
    Mushtaque, Md
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [39] The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers
    Iyer, R. Sumanth
    Nicol, Samantha M.
    Quinlan, Philip R.
    Thompson, Alastair M.
    Meek, David W.
    Fuller-Pace, Frances V.
    CELL CYCLE, 2014, 13 (09) : 1413 - 1423
  • [40] Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer
    Fristrup, Niels
    Ulhoi, Benedicte P.
    Birkenkamp-Demtroder, Karin
    Mansilla, Francisco
    Sanchez-Carbayo, Marta
    Segersten, Ulrika
    Malmstrom, Per-Uno
    Hartmann, Arndt
    Palou, Joan
    Alvarez-Mugica, Miguel
    Zieger, Karsten
    Borre, Michael
    Orntoft, Torben F.
    Dyrskjot, Lars
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (05): : 1824 - 1834